prikaz prve stranice dokumenta Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
  Preuzmi
PDF 66.75 KB
Stručni rad - Uvodnik
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
Croatian Medical Journal, 59 (2018), 3; 97-99. https://doi.org/10.3325/cmj.2018.59.97
Mikolašević, Ivana; Bokun, Tomislav; Filipec Kanižaj, Tajana

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Mikolašević, I., Bokun, T. i Filipec Kanižaj, T. (2018). Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?. Croatian Medical Journal, 59. (3), 97-99. doi: 10.3325/cmj.2018.59.97

Mikolašević, Ivana, et al. "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?." Croatian Medical Journal, vol. 59, br. 3, 2018, str. 97-99. https://doi.org/10.3325/cmj.2018.59.97

Mikolašević, Ivana, Tomislav Bokun i Tajana Filipec Kanižaj. "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?." Croatian Medical Journal 59, br. 3 (2018): 97-99. https://doi.org/10.3325/cmj.2018.59.97

Mikolašević, I., Bokun, T. i Filipec Kanižaj, T. (2018) 'Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?', Croatian Medical Journal, 59(3), str. 97-99. doi: 10.3325/cmj.2018.59.97

Mikolašević I, Bokun T, Filipec Kanižaj T. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?. Croatian Medical Journal [Internet]. 2018. [pristupljeno 07.11.2024.];59(3):97-99. doi: 10.3325/cmj.2018.59.97

I. Mikolašević, T. Bokun i T. Filipec Kanižaj, "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?", Croatian Medical Journal, vol. 59, br. 3, str. 97-99, 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:226771. [Citirano: 07.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:226771
Podaci o radu
Naslov (engleski)Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
AutorIvana Mikolašević
AutorTomislav Bokun
AutorTajana Filipec Kanižaj
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Almost 25% of all human cancers are located in the gastrointestinal tract (GIT), making it the dominant cancer-affected site. The reason for this could be constant GIT exposure to organ damage and chronic inflammation (1). Despite all medical breakthroughs, less than half of patients survive one year after the esophageal adenocarcinoma (EAC) diagnosis (2). Most malignancies, including most GIT malignancies, are preceded by precursor/premalignant lesions. Premalignant condition for EAC development is Barrett esophagus (BE), a disorder characterized by abnormal transformation of the squamous epithelium. BE is strongly associated with prolonged gastro-esophageal reflux of gastric and bile acids (1,3,4). Since patients with BE carry 30-40 times higher risk for EAC than general population, it is not surprising that in the last 10-20 years the research interest in BE has been growing (3)
Jezikengleski
Vrsta publikacijeStručni rad - Uvodnik
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCroatian Medical Journal
Brojčani podacivol. 59, br. 3, str. 97-99
p-ISSN0353-9504
e-ISSN1332-8166
DOIhttps://doi.org/10.3325/cmj.2018.59.97
URN:NBNurn:nbn:hr:184:226771
Datum objave publikacije2018
URL dokumentahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045895/
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2022-03-22 13:34:07